KARVEZIDE 300/25 irbesartan 300mg and hydrochlorothiazide 25mg tablet blister pack Austrália - inglês - Department of Health (Therapeutic Goods Administration)

karvezide 300/25 irbesartan 300mg and hydrochlorothiazide 25mg tablet blister pack

sanofi-aventis australia pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: iron oxide red; iron oxide yellow; croscarmellose sodium; silicon dioxide; carnauba wax; lactose monohydrate; microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; titanium dioxide; hypromellose; macrogol 3350; iron oxide black - karvezide is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

AVAPRO HCT 300/25 irbesartan 300mg and hydrochlorothiazide 25mg tablet blister pack Austrália - inglês - Department of Health (Therapeutic Goods Administration)

avapro hct 300/25 irbesartan 300mg and hydrochlorothiazide 25mg tablet blister pack

sanofi-aventis australia pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: silicon dioxide; microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; iron oxide yellow; magnesium stearate; carnauba wax; croscarmellose sodium; iron oxide red; titanium dioxide; hypromellose; macrogol 3350; iron oxide black - avapro hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

APO-IRBESARTAN  HCTZ 300/12.5 irbesartan and hydrochlorothiazide 300/12.5mg tablet blister pack Austrália - inglês - Department of Health (Therapeutic Goods Administration)

apo-irbesartan hctz 300/12.5 irbesartan and hydrochlorothiazide 300/12.5mg tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; magnesium stearate; croscarmellose sodium; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000 - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

APO-IRBESARTAN HCTZ 150/12.5 irbesartan and hydrochlorothiazide 150/12.5mg tablet blister pack Austrália - inglês - Department of Health (Therapeutic Goods Administration)

apo-irbesartan hctz 150/12.5 irbesartan and hydrochlorothiazide 150/12.5mg tablet blister pack

arrotex pharmaceuticals pty ltd - irbesartan, quantity: 150 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; lactose monohydrate; croscarmellose sodium; iron oxide yellow; iron oxide red; titanium dioxide; hypromellose; macrogol 4000 - for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

IRBESARTAN/HCT SANDOZ  300/25 irbesartan 300 mg/hydrochlorothiazide 25 mg film-coated tablet blister pack Austrália - inglês - Department of Health (Therapeutic Goods Administration)

irbesartan/hct sandoz 300/25 irbesartan 300 mg/hydrochlorothiazide 25 mg film-coated tablet blister pack

sandoz pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: hypromellose; iron oxide black; macrogol 6000; colloidal anhydrous silica; lactose monohydrate; titanium dioxide; croscarmellose sodium; purified talc; microcrystalline cellulose; hyprolose; iron oxide red; magnesium stearate - irbesartan/hct sandoz is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

IRBESARTAN HCT MYLAN 300/25 irbesartan/hydrochlorothiazide 300/25 mg tablet bottle Austrália - inglês - Department of Health (Therapeutic Goods Administration)

irbesartan hct mylan 300/25 irbesartan/hydrochlorothiazide 300/25 mg tablet bottle

alphapharm pty ltd - hydrochlorothiazide, quantity: 25 mg; irbesartan, quantity: 300 mg - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate; sodium lauryl sulfate; povidone; lactose monohydrate; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 3350; iron oxide black - abisart hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Irbesartan HCTZ MLabs 300/25 irbesartan 300 mg and hydrochlorothiazide 25 mg tablets blister pack Austrália - inglês - Department of Health (Therapeutic Goods Administration)

irbesartan hctz mlabs 300/25 irbesartan 300 mg and hydrochlorothiazide 25 mg tablets blister pack

micro labs pty ltd - hydrochlorothiazide, quantity: 25 mg; irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; sodium starch glycollate type b; polysorbate 80; mannitol; hypromellose; magnesium stearate; povidone; titanium dioxide; iron oxide red; macrogol 3350; carnauba wax; iron oxide black - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Irbesartan HCTZ MLabs 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablets blister pack Austrália - inglês - Department of Health (Therapeutic Goods Administration)

irbesartan hctz mlabs 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablets blister pack

micro labs pty ltd - irbesartan, quantity: 150 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: polysorbate 80; sodium starch glycollate type b; colloidal anhydrous silica; mannitol; hypromellose; povidone; magnesium stearate; titanium dioxide; iron oxide yellow; iron oxide red; carnauba wax; macrogol 3350 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.